MedPath

Feasibility study of risk reducing mastectomy (RRM) for BRCA1/2 mutation carriers

Not Applicable
Conditions
Hereditary breast and ovarian cancer
Registration Number
JPRN-UMIN000038061
Lead Sponsor
Mie University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1.The case in which doctor does not approve to perform RRM 2.Pregnant woman or woman with a possibility of pregnant 3.Doctor's decision not to be registered to this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety of RRM for BRCA1/2 mutation carriers Incidence of complications related to surgery
Secondary Outcome Measures
NameTimeMethod
Incidence of occult breast cancer for RRM Incidence of breast cancer during 2 years after RRM
© Copyright 2025. All Rights Reserved by MedPath